Figure 1.

Mean serum protein levels of insulin-like growth factor binding protein 2 (IGFBP2) and mesothelin (MSLN). IGFBP2 (a) and MSLN (b) were measured in serum samples obtained from healthy control subjects (CON), patients with chronic pancreatitis (ChPT) and pre-treatment patients with confirmed pancreatic ductal adenocarcinoma (PDAC). Error bars represent a standard deviation. *P = 0.069 versus CON, P = 0.0002 versus ChPT and P = 0.0022 versus CON + ChPT. †P = 0.0003 versus CON, P = 0.042 versus ChPT and P = 0.0002 versus CON + ChPT